종근당바이오

063160KOSPI의약품 제조업

50.5 / 100

Reference Date: 2026-07-24

Financial Score15.5 / 40

News Sentiment20.0 / 25

Momentum5.0 / 20

Disclosure10.0 / 15

AI Analysis: PBR is significantly undervalued vs. peers but ROE is below the industry average. Roughly flat over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

CKDBio is a fermentation and biotechnology specialist established in 2001, operating core businesses in API, probiotics, microbiome, and botulinum toxin. Leveraging over 50 years of technical expertise and adherence to global cGMP standards, the company supplies high-value products to over 40 countries. In the botulinum toxin sector, it has secured China NMPA Phase 3 clinical approval, actively expanding its global market presence.

Number of Employees

533people

Average Salary

69.0M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 11.234.0Point

PBR

0.58Industry Average 0.815.5Point

Lower than industry avg (good)

ROE

-2.24Industry Average 4.010.0Point

Well below industry avg

Debt Ratio

16.37Industry Average 12.432.0Point

Higher than industry avg (caution)

Trend 2023~20254.0 / 10 points

Revenue Growth Rate

1.0 / 3

Avg ▲0.2% (2-year basis)

Operating Profit Growth Rate

3.0 / 3

Avg ▲43.6% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -4.4% (improving, 3yr)

Detailed News Sentiment

4 totalPositive 4Neutral 0Negative 0Average Sentiment Score 80

Positive
종근당바이오, ‘티엠버스주’ 출시 1주년 심포지엄…내달 ‘200유닛’....
종근당바이오의 신균주 보툴리눔 톡신 '티엠버스주' 출시 기념 심포지엄 개최로 긍정적인 시장 반응 예상.
Positive
"임상 경험·시술 트렌드 공유"…종근당바이오, '티엠버스주' 1주년 ...
종근당바이오의 보툴리눔 톡신 '티엠버스주' 출시 1주년 심포지엄을 통해 임상 경험과 최신 트렌드 공유로 제품 차별성 강조.
Positive
"임상 경험 공유"…종근당바이오, 심포지엄 개최
종근당바이오의 보툴리눔 톡신 '티엠버스주' 출시 1주년 기념 심포지엄 개최로 인해 긍정적인 시장 반응 예상.

Detailed Momentum

52-week position1.0Point

Near 52w low (7%, downtrend)

Current 13,320Won52-week high 24,50052-week low 12,430

1-month return3.0Point

1m 0% (flat)

Volume trend1.0Point

Volume decreasing

Detailed Disclosure

1 totalPositive 0Neutral 1Negative 0

Neutral지속가능경영보고서등관련사항(자율공시)2026-06-26